1
Registered trials
0
Recruiting
1
Unique sponsors
1
Unique IMPs
0
Commercial trials
Drug classes (ATC)
L
Oncology (ATC L)
1
Mechanism of action (INN-stem analysis)
RAF/BRAF inhibitor
1 substance
Phase II:
1
Phase II
1 trial-
EndedUnicancer AcademicREGORAFENIB
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Unicancer | Academic | 1 | Phase II | 0 |